Physician profile
Angela Beth Walker
NPI 1568703957
$682.77
in general payments reported to CMS, 2019-2025
12 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.15 · 2022: $28.22 · 2023: $286 · 2024: $171 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $336.44 | 2023-2025 | Hizentra |
| Abbvie INC. | $74.28 | 2024-2025 | |
| Neurelis, INC. | $51.96 | 2023 | Valtoco |
| Octapharma USA, INC. | $43.92 | 2025 | Octagam Immune Globulin (Human) |
| Pfizer INC. | $34.22 | 2024-2025 | |
| Masimo Corporation | $28.22 | 2022 | |
| Lilly USA, LLC | $24.68 | 2023 | Emgality, Reyvow |
| Genentech USA, INC. | $23.87 | 2025 | Ocrevus Zunovo |
| Biogen, INC. | $20.78 | 2025 | Vumerity, Tysabri |
| Lundbeck LLC | $17.43 | 2023 | Vyepti |
| Ucb, INC. | $15.82 | 2025 | Rystiggo |
| Allergan, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.